Navigation Links
Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation
Date:7/13/2014

Columbus, OH (PRWEB) July 13, 2014

A Xarelto lawsuit webpage has been launched by Wright & Schulte LLC to provide consumers with the most current information regarding serious internal bleeding that can sometimes accompany use of the blood-thinning medication, as well as the growing number of Xarelto bleeding lawsuits pending in courts around the country. The law firm is now offering free legal evaluations to anyone who may have suffered from life-threatening internal bleeding and related complications while using Xarelto, including:

  •     Gastrointestinal Bleeding
  •     Cerebral Hemorrhage
  •     Heart Attack
  •     Stroke
  •     Blood Clots
  •     Death

Xarelto is a blood thinner that is used for a number of indications, including the prevention of blood clots related to atrial fibrillation, and the treatment of dangerous blood clots called deep vein thrombosis and pulmonary embolism. It is also given to patients who have just had hip or knee replacement surgery to reduce the risk of blood clots in the legs and lungs. Xarelto was approved by the U.S. Food & Drug Administration (FDA) in 2011, and is manufactured by Bayer HealthCare. Janssen Pharmaceutical, a division of Johnson & Johnson, markets Xarelto in the U.S.
(fda.gov/downloads/Drugs/DrugSafety/
UCM280333.pdf, FDA, March 2014)

All blood thinners, including Xarelto, can cause patients to suffer internal hemorrhaging. However, there currently exists no antidote to reverse Xarelto bleeding. Since its approval, the drug has been the subject of several FDA safety alerts. In August 2013, a boxed warning was added to the Xarelto label advising that premature discontinuation of the drug increases the risk of thrombotic events. The FDA also warned that epidural or spinal hematomas with the potential to cause long-term or permanent paralysis could occur in Xarelto patients who receive anesthesia or undergo spinal puncture.
(fda.gov/safety/medwatch/safetyinformation/ucm367392.htm, FDA, March 2014)

According to a report published by Reuters last month, at least 10 Xarelto lawsuit claims have been filed in U.S. courts on behalf of patients who may have been injured by the blood thinner. Most recently, a Florida woman filed a wrongful death lawsuit on behalf of her husband, who allegedly died due to uncontrollable bleeding caused by Xarelto. Among other things, the complaint, which was filed on June 23, 2014 in U.S. District Court, Southern District of Florida, claims that the manufacturers of Xarelto failed to warn that there was no reversal agent for Xarelto bleeding. The lawsuit further alleges that Xarelto is unreasonably dangerous and defective, and points out that safer alternatives exist, such as warfarin, which have reversal agents for internal bleeding. (Case 0:14-cv-61448-JAL)
(reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, June 14, 2014)

The attorneys of Wright & Schulte LLC believe that additional Xarelto lawsuits involving similar allegations will be filed against the manufacturers of this medication in the coming months. The Firm is offering free, no-obligation legal reviews to anyone who suffered serious internal bleeding and related complications due to their use of Xarelto. To learn more, or to arrange for a free legal consultation with an attorney at Wright & Schulte LLC, please visit yourlegalhelp.com.

About Wright & Schulte LLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free Xarelto lawsuit case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
http://www.yourlegalhelp.com
Like us on Facebook
Follow us on Twitter
Join us on Google+

Read the full story at http://www.prweb.com/releases/2014/07/prweb12013070.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
2. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure
3. DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant
4. Just for Men Lawsuit News: TV Campaign Launched by Wright & Schulte LLC to Inform Consumers of the Alleged Association between the Popular Hair Dye and Chemical Burns
5. Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing
6. Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators
7. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
8. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
9. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
10. Best Transvaginal Mesh Attorneys? LawsuitLegal.com Now Accepting Surgical Mesh Failure Victim Inquiries
11. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey DePuy ASR Recall Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... 2017 , ... The John P. McGovern Museum of Health and Medical Science ... their cognitive health, and share results with their physicians. Members and guests can sign ... website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... ... April 24, 2017 , ... Salus Telehealth, Inc. ... company’s VideoMedicine mobile platform has launched Quick Care, a new service offering on-demand ... Care provides patients with the option to request and begin a consultation with ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... Tx (PRWEB) , ... April 24, 2017 , ... ... Lief Therapeutics designed to recognize elevated anxiety levels in people with addiction who ... the Lief Smart Patch, a biosensing wearable device that monitors heart and breath ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Vivify Health, the pioneer ... has been awarded a very significant patent for the ... to continual care via digital health.  This landmark patent ... property and further secures Vivify,s position as the leader ... 2009, was the first company to apply consumer mobile ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: